Thailand PGT IVF Hospital Selection Criteria and Process: Preimplantation Genetic Testing Institution Detailed Explanation

Opening: Real medical experience (Module 8)

Real Case Contributed by Medical Editor

A 42-year-old woman presented for consultation after two first-trimester spontaneous miscarriages. Chromosome karyotype analysis revealed she was a carrier of a balanced translocation 46,XX,t(4;12)(q31;q23). She and her husband completed an IVF cycle at a reproductive center in Thailand with PGT-SR testing capability. 14 eggs were retrieved, 7 blastocysts formed. After blastocyst trophectoderm biopsy and aCGH analysis, one embryo with balanced chromosome signals was confirmed. Clinical pregnancy was achieved after frozen embryo transfer, and second-trimester amniotic fluid karyotype verification results were consistent with the PGT findings. This case truly reflects the clinical value of Thai PGT hospitals in detecting chromosomal structural rearrangements and also raises a core question: how to evaluate and select a Thai IVF hospital with PGT capabilities.

PGT Technology Types and Suitable Populations

Preimplantation genetic testing (PGT) is divided into three types based on testing purposes, with varying applications in Thai PGT IVF hospitals.

When choosing a Thai PGT IVF hospital, you first need to clarify which type of PGT technology applies to you. Some hospitals only offer PGT-A, while institutions with genetics teams and genetic counseling capabilities can complete case design for PGT-M and PGT-SR.

Evaluation Dimensions of Thai PGT Hospitals

Evaluating whether a Thai PGT IVF hospital is reliable cannot rely solely on success rate numbers; analysis from five core dimensions is necessary.

1. Laboratory Accreditation and Quality Standards

Internationally recognized accreditations include ISO 15189 (Medical laboratory quality system) and CAP (College of American Pathologists) certification. Some Thai reproductive centers also hold RTAC (Reproductive Technology Accreditation Committee, Australia) or JCI (Joint Commission International) certification. The laboratory's quality control data (e.g., post-biopsy blastocyst survival rate, test result concordance rate) are more informative than the certifications themselves.

2. Genetics Team Configuration

Case design for PGT-M and PGT-SR requires collaboration among clinical geneticists, genetic counselors, and molecular biologists. Whether the hospital has its own genetics laboratory or sends biopsy samples to a third-party genetic testing company directly impacts the testing turnaround time and communication efficiency.

3. Embryo Biopsy Technique and Timing

The current mainstream method is Day 5/6 blastocyst trophectoderm biopsy (3-6 cells). The stability of the biopsy technique (cell integrity rate, DNA amplification success rate) is a core indicator. Experience with laser-assisted biopsy varies among different Thai laboratories.

4. Genetic Testing Platform

Common platforms include NGS (next-generation sequencing), aCGH (array comparative genomic hybridization), and SNP array. NGS offers high throughput and can simultaneously detect chromosomal numbers and some structural abnormalities, making it the mainstream choice in Thai PGT hospitals. aCGH has certain advantages in detecting mosaicism, but its resolution is limited by the platform.

5. Embryo Culture System and Blastocyst Formation Rate

PGT requires culture to the blastocyst stage for biopsy, so the laboratory's blastocyst formation rate directly affects the number of embryos available for testing. A stable culture system (low oxygen culture, sequential media, time-lapse monitoring) is a fundamental guarantee.

Actual Treatment Process (Using a Thai PGT Cycle as an Example)

From initial consultation to transfer, a complete service cycle at a Thai PGT IVF hospital typically takes 3-4 months, with specific steps as follows:

• Step 1 Genetic Counseling and Preliminary Tests: The couple completes chromosome karyotype analysis, carrier screening (based on genetic family history), infectious disease screening, semen analysis, and ovarian reserve assessment (AMH, FSH, antral follicle count). Also confirm passport validity (recommended > 6 months).
• Step 2 Ovarian Stimulation and Egg Retrieval: Approximately 10-12 days after cycle start, transvaginal egg retrieval is performed. Most Thai hospitals use antagonist protocols or mild stimulation protocols, adjusted based on AMH and age.
• Step 3 Fertilization and Blastocyst Culture: After ICSI fertilization, embryos are cultured in a time-lapse incubator until Day 5/6. Blastocyst grades (e.g., 4AA, 4BB) are recorded.
• Step 4 Embryo Biopsy: 3-6 cells are aspirated from the blastocyst trophectoderm. The blastocyst is immediately vitrified after biopsy.
• Step 5 Genetic Testing and Genetic Counseling: Biopsy samples are sent to the genetics laboratory. PGT-A takes about 5-7 business days. PGT-M and PGT-SR require family study design first, taking about 10-20 business days. The test report is interpreted by a genetic counselor, explaining chromosome status, mosaicism ratio, and clinical recommendations.
• Step 6 Frozen Embryo Transfer: A chromosomally normal (or balanced) embryo is selected for frozen embryo transfer in a natural or artificial cycle. Blood HCG is tested 12-14 days after transfer.
• Step 7 Prenatal Diagnosis Confirmation: After clinical pregnancy, amniocentesis for karyotype analysis is recommended in the second trimester to verify PGT results. PGT-M requires confirmation through prenatal genetic diagnosis.

Comparison of Major Thai PGT Hospitals

The following provides an objective comparison of different categories of Thai PGT IVF hospitals based on laboratory and genetic service dimensions. Data is derived from public information and practitioner feedback.

When choosing, note: Large private centers offer high service efficiency but higher costs; university-affiliated centers have deeper genetics backgrounds but may have less process flexibility. The capability for PGT-M and PGT-SR case design is a key differentiator between the two types of hospitals.

Easily Overlooked Details

• Post-biopsy blastocyst freeze-thaw survival rate: Data reported by Thai laboratories ranges from 80% to 95%. Ask for specific quality control data. Rates below 85% should raise concern.
• Clinical interpretation of mosaic embryos: About 5%-8% of PGT-A results show low-level mosaicism (20%-40%). Recommendations for transferring mosaic embryos vary significantly between hospitals; some centers advise against it, while others provide counseling based on the mosaicism ratio and chromosome type.
• Necessity of chromosome karyotype analysis for both partners: Not all hospitals require karyotype analysis before PGT. For recurrent miscarriage or severe male oligoasthenospermia, karyotype analysis can reveal occult balanced translocations.
• Accurate disclosure of genetic family history: PGT-M requires identification of the pathogenic gene and mutation site. Incomplete family history information (e.g., untested proband) may lead to failure in family study design.

Frequently Asked Questions

Q1: Can PGT improve embryo implantation rate?

PGT-A can select chromosomally euploid embryos. For women of advanced maternal age (≥38 years), it can reduce implantation failure and early miscarriage rates caused by chromosomal abnormalities, but it does not improve the implantation potential of each individual egg or embryo. For non-advanced age groups, PGT-A has not been shown to improve cumulative live birth rates.

Q2: Can PGT completely prevent genetic diseases?

PGT-M can block the intergenerational transmission of known single-gene disorders, but there is a very low probability (<1%) of testing technology errors and genetic recombination errors. All PGT offspring are still recommended to undergo prenatal diagnosis for confirmation.

Q3: What items are included in the Thailand PGT cost?

Typically includes: ovarian stimulation medication, egg retrieval surgery, ICSI fertilization, blastocyst culture, biopsy, genetic testing (PGT-A or PGT-M/SR), and one frozen embryo transfer. Some hospitals do not include: genetic counseling fees, family pre-test fees, additional freezing fees, and embryo storage fees.

Q4: Must carriers of balanced chromosomal translocations undergo PGT-SR?

In natural conception, the probability of a balanced translocation carrier producing chromosomally unbalanced gametes is 30%-80%, depending on the translocation type and breakpoints. PGT-SR can significantly reduce the risk of miscarriage but cannot completely eliminate it (due to recombination during gamete formation). For young carriers who have had normal offspring from natural conception and no history of miscarriage, discussing natural conception with prenatal diagnosis options with a genetic doctor is also possible.

When is it Suitable / Unsuitable to Choose a Thai PGT IVF Hospital

• Suitable: Individuals aged ≥38 years, with a history of recurrent miscarriage, chromosomal abnormalities (balanced translocation/Robertsonian translocation), carriers of single-gene disorders, previous IVF recurrent implantation failure, and those requiring sex selection (for medical indications).
• Unsuitable: Individuals with severely diminished ovarian function (AMH < 0.5 ng/mL), those unable to accept a frozen embryo transfer cycle, those with PGT contraindications (e.g., high mosaicism ratio, uncontrolled uterine pathology), and those with time constraints for the testing cycle.

AMH FSH Chromosome Karyotype Genetic Counseling Blastocyst Biopsy NGS aCGH Mosaicism PGT-A PGT-M PGT-SR Frozen Embryo Transfer Prenatal Diagnosis Balanced Translocation Carrier Screening